Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,721 INR | +0.35% | +1.51% | -9.26% |
Apr. 16 | Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak | CI |
Mar. 28 | Alkem Laboratories Forms Subsidiary for Medical Devices Business | MT |
Sales 2024 * | 129B 1.55B | Sales 2025 * | 142B 1.71B | Capitalization | 564B 6.78B |
---|---|---|---|---|---|
Net income 2024 * | 18.67B 224M | Net income 2025 * | 21.7B 261M | EV / Sales 2024 * | 4.22 x |
Net cash position 2024 * | 20.12B 242M | Net cash position 2025 * | 27.86B 334M | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
30.7
x | P/E ratio 2025 * |
26.1
x | Employees | 16,871 |
Yield 2024 * |
0.92% | Yield 2025 * |
1.04% | Free-Float | 36.2% |
Latest transcript on Alkem Laboratories Limited
1 day | +0.35% | ||
1 week | +1.51% | ||
Current month | -4.47% | ||
1 month | -5.62% | ||
3 months | -5.57% | ||
6 months | +31.67% | ||
Current year | -9.26% |
Managers | Title | Age | Since |
---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 23-09-21 |
Nitin Agrawal
DFI | Director of Finance/CFO | - | Jan. 31 |
Manish Narang
CMP | Compliance Officer | 54 | 06-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Director/Board Member | 77 | 15-03-15 | |
Chief Executive Officer | 84 | 73-08-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 6 M€ | +6.07% | - | |
0.01% | 31 M€ | +3.19% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 4,721 | +0.35% | 55 269 |
24-04-23 | 4,704 | -0.87% | 145,622 |
24-04-22 | 4,746 | +2.80% | 188,465 |
24-04-19 | 4,616 | -0.74% | 94,277 |
24-04-18 | 4,651 | -1.76% | 314,802 |
Delayed Quote NSE India S.E., April 24, 2024 at 07:40 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.26% | 6.75B | |
+26.31% | 672B | |
+25.98% | 570B | |
-5.61% | 360B | |
+16.12% | 321B | |
+9.01% | 300B | |
+6.92% | 217B | |
-9.49% | 204B | |
+5.29% | 199B | |
-9.15% | 149B |
- Stock Market
- Equities
- ALKEM Stock